R. Ruffin (Woodville, South Aus., Australia), J. Garcia Aymerich (Barcelona, Spain)
Depression prevalence in COPD and matched non-COPD cohorts
H. Mullerova, R. Baxter, J. B. Soriano, K. J. Davis (Greenford, United Kingdom; Mallorca, Spain; RTP, United States Of America)
|  |
Health status comparison of patients with COPD throughout the world: the BOLD Initiative
K. B. Weiss, T. A. Lee, S. D. Sullivan, W. Vollmer, A. S. Buist (Chicago, Seattle, Portland, United States Of America)
| |
Validation of the Saint George‘s respiratory questionnaire in patients with chronic obstructive pulmonary disease in Morocco
K. El Rhazi, C. Nejjari, M. C. Benjelloun, J. E. Bourkadi, S. Zaid, E. Assbaai, P. Barberger-Gateau (Fez, Rabat, Morocco; Bordeaux, France)
| |
Comparison of the quality of life of COPD patients between the United Arab Emirates and the United Kingdom
I. Ben Bihi, M. Shamssain, M. Farrow, M. Al Sayegh, S. Nasir, G. Burns (Sunderland, Newcastle, United Kingdom; Dubai, United Arab Emirates)
| |
Lung function in patients attending a rapid access chest pain clinic
H. C. Francis, W. V. Colecliffe, M. L. Hazell, D. Singh, R. M. Niven, G. W. Hagan, M. D. Spencer, T. L. Frank (Manchester, Greenford, United Kingdom)
| |
Forecasting COPD winter hospital admissions to promote anticipatory care in England
P. M. Marno, H. A. Watkin, C. Bryden, M. Gibbs (Exeter, United Kingdom)
| |
Post-bronchodilator spirometry reduces COPD diagnosis rate by 30%
M. Bednarek, J. Maciejewski, R. Plywaczewski, D. Gorecka, J. Zielinski (Warsaw, Sierpc, Poland)
| |
Usefulness of the chest CT scanning for screening of emphysema in 40,924 Japanese undergoing routine medical checkup
M. Fukakusa, N. Nishimura, M. Tsukamoto, N. Uchiyama, K. Oikado, M. Matsusako, A. Hayashibe, F. Kinoshita, N. Chonabayashi, S. Hiramatsu (Tokyo, Japan)
| |
Participant and technician predictors of spirometry quality factors in the multi-ethnic study of atherosclerosis
K. Stukovsky, J. Hankinson, R. Jiang, W. C. Johnson, S. Kawut, L. Smith, R. G. Barr (Seattle, Valdosta, New York, Chicago, United States Of America)
| |
Use of respiratory drugs, flu vaccination and anti-smoking advice in patients with COPD from 5 Latin American cities: the PLATINO Study
M. V. Lopez Varela, A. Muinio, A. Menezes, P. Hallal, R. Perez Padilla, J. Jardim, G. Valdivia, J. Pertuze, C. Talamo, M. Montes de Oca, R. Halbert (Uruguay; Brazil; Mexico; Chile; Venezuela; USA)
| |
Short- and long-term mortality of COPD patients treated in the respiratory intensive care unit for acute respiratory failure
T. Yarkin, D. Demiryontar, Z. Karakurt, N. Adiguzel, H. Altinoz (Istanbul, Turkey)
| |
Maximal inspiratory pressure predicts mortality in patients with chronic obstructive pulmonary disease in five year follow-up period
V. A. Hodzhev, S. S. Kostianev (Plovdiv, Bulgaria)
| |
The ratio of lean-to-fat mass and functional limitation in COPD
M. D. Eisner, C. Iribarren, E. H. Yelin, S. Sidney, P. P. Katz, P. V. Lathon, I. Tolstykh, P. D. Blanc (San Francisco, Oakland, United States Of America)
| |
Declared work loss in active subjects with undiagnosed airflow obstruction from the general population
N. Roche, F. Dalmay, T. Perez, C. Kuntz, J. P. Giordanella, F. Neukirch, A. Vergnenègre, G. Huchon (Paris, France)
| |
Comparative study about the permanent work capacity impairment in COPD and asthma
N. I. Olimpia (Bucharest, Romania)
| |
Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease
V. Pyankov, Y. Chuyasova (Kirov, Russian Federation)
| |
Nutritional distribution in COPD
A. Baccioglu, T. Acican (Ankara, Turkey)
| |
Frequency of α-1 antitrypsin deficiency (AATD) in a population screening in an high risk area (Val Trompia, Italy)
N. Gatta, L. Corda, D. Medicina, G. Moretti, F. Facchetti, E. Bertella, V. Pinelli, M. Barbaglio, B. Balbi (Sarezzo, Brescia, Gussago, Italy)
| |
Alpha1-antitrypsin deficiency-related PI*Z and PI*S alleles in a random sample of Polish population
M. Kaczor, M. Sanak, A. Szczeklik (Krakow, Poland)
| |